Business · 10/03/2000
FDA Releases Draft Guidance for PET Drug Applications
The Food and Drug Administration (FDA) has made available a draft guidance document to help manufacturers of positron emission tomography (PET) drugs prepare and submit new drug applications (NDAs) or abbreviated new drug applications (ANDAs) for certain PET drug products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →